USP's Therapeutic Peptides Expert Panel discusses manufacturing processes and impurity control for synthetic peptide APIs.
Brian Gregg
Advertisement
Brian Gregg is chief operating officer at Bachem Americas.
Articles by Brian Gregg
USP evaluates raw materials used in the chemical synthesis of peptides.
USP evaluates quality attributes for synthetic peptides.
Advertisement
Latest Updated Articles
Control Strategies for Synthetic Therapeutic Peptide APIs Part II: Raw Material ConsiderationsPublished: April 2nd 2014 | Updated:
Control Strategies for Synthetic Therapeutic Peptide APIs—Part I: Analytical ConsiderationPublished: March 2nd 2014 | Updated:
Control Strategies for Synthetic Therapeutic Peptide APIs Part III: Manufacturing Process ConsiderationsPublished: May 2nd 2014 | Updated:
Advertisement
Advertisement
